Research articleVitamin D and risk of ankylosing spondylitis: A two-sample mendelian randomization study
Introduction
Ankylosing spondylitis (AS) is an immune-mediated, chronic, inflammatory disease of the axial spine that can lead to bone hyperplasia and ankylosis [1]. However, until now, the exact cause of AS is still unknown, but it is certain that any single cause cannot fully explain the etiology of AS.
Many environmental and genetic factors are suspected of triggering ankylosing spondylitis, but their role was unclear. Among these, vitamin D supplementation has been identified as a preventive factor, but research on its effect on the development of ankylosing spondylitis has been inconsistent. Vitamin D is a type of lipid-soluble vitamin, but actually contains two related lipid-soluble substances, namely cholecalciferol (vitamin D3) and ergocalciferol (vitamin D2). In the liver, vitamin D is metabolized as 25-hydroxyvitamin D [25(OH)D] by microsomal enzymes and hepatocyte mitochondria. The vitamin D3 acts on the intestine, stomach, kidney, and other target organs to regulate calcium and phosphorus levels through its main active metabolites [1,25(OH)D3]. In addition, vitamin D has an immunomodulatory function and is a good selective immunomodulator [2]. When the immune function of the body is inhibited, the immune function can be enhanced by enhancing the functions of monocytes and macrophages [3]. On the contrary, when the immune function is abnormally increased, it will inhibit the proliferation of activated T lymphocyte cells and B lymphocyte cells to maintain the immune balance. Meta-analysis results from previous observational studies indicate that vitamin D levels were inversely associated with the risk of AS [4], [5].
Mendelian randomization (MR) uses genetic variation as instrumental variables (IVs) to determine whether observed correlations between risk factors and outcomes are consistent with causal effects [6]. At present, this approach has been applied to elucidate the causal relationship between the outcomes of disease by exposure factors [7], [8], [9]. Compared with the one-sample MR method, the two-sample MR (TSMR) method is effective and powerful in obtaining associations between “genetic risk factors” and “genetic outcomes” by using the independent results of two genome-wide association studies (GWAS) in the same population [10]. However, this approach has not previously been used to explore the causal relationship between vitamin D and AS risks. In this study, we conducted the TSMR analysis to explore whether vitamin D levels were causally associated with the risk of AS.
Section snippets
Data sources and study design
In our study, single-nucleotide polymorphisms (SNPs) were defined as IVs. To obtain exposure group data, the SNPs closely associated with vitamin D levels (P < 5 × 10−8) at a genome-wide significance level were selected, including 79,366 European-ancestry individuals [11]. To avoid bias due to linkage disequilibrium (LD) relationship in analysis, the LD of SNPs that are closely associated with vitamin D levels has to meet the condition r2 < 0.001 [12]. The SNPs associated with obesity [13],
Instrumental variables
Table 1 describes the characteristic information of SNPs on vitamin D and AS. Finally, we selected four SNPs as IVs (rs3755967, rs12785878, rs10741657 and rs10745742). All of them were associated with vitamin D levels at genome-wide significance. These SNPs explained 5.31% of the variation in vitamin D concentrations. The strength of selected single-IVs, their F-statistics value was ranged from 59 to 1497. Thus, none of these SNPs were excluded for becoming weak IVs.
TSMR analysis results
The results of IVW show that
Discussion
To our knowledge, the causal relationship between vitamin D levels and AS has not been confirmed so far. Therefore, we studied the causal relationship between vitamin D levels and AS. The results of four different estimation methods for the MR analyses were consistent. The TSMR estimate for the serum vitamin D-to-AS relation was unlikely to be causal.
Vitamin D is not only involved in calcium, phosphorus, and bone metabolism, but also has an obvious immunomodulatory effect. It plays an important
Conclusion
In conclusion, the causal effects of vitamin D levels and the risk for AS were not found in our study. Epidemiology suggests that vitamin D levels are inversely associated with AS risk, but this is not the cause-and-effect.
Author contributions
The paper was written through the contributions of all authors. All authors have given approval to the final version of the paper. Jinjin Jiang and Ming Shao contributed equally to this work and should be considered as co-first authors.
Funding
This study was supported by grants from the applied medicine research project of Hefei Health and Family Planning Commission, Anhui Province, China (hwk2016zc019) and the scientific research project of Anhui Blood Center (2015AHBC02).
Conflict of interest
The authors declare that there is no conflict of interest.
Declaration of Competing Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper
References (33)
- et al.
Spondyloarthritis
Lancet
(2011) - et al.
Vitamin D in ankylosing spondylitis: review and meta-analysis
Clin. Chim. Acta
(2015) - et al.
Linkage disequilibrium in humans: models and data
Am. J. Hum. Genet.
(2001) - et al.
Cochran’s Q test was useful to assess heterogeneity in likelihood ratios in studies of diagnostic accuracy
J. Clin. Epidemiol.
(2015) - et al.
Emerging role of vitamin D in autoimmune diseases: an update on evidence and therapeutic implications
Autoimmun. Rev.
(2019) - et al.
Vitamin D: nutrient, hormone, and immunomodulator
Nutrients
(2018) - et al.
In vitro exposure of human blood mononuclear cells to active vitamin D does not induce substantial change to DNA methylation on a genome-scale
J. Steroid. Biochem.
(2014) - et al.
Serum vitamin D level and rheumatoid arthritis disease activity: review and meta-analysis
PLoS One
(2016) - et al.
Mendelian randomization
JAMA
(2017) - et al.
Circulating adiponectin levels and systemic lupus erythematosus: a two-sample Mendelian randomization study
Rheumatology
(2020)
Alcohol intake and risk of systemic lupus erythematosus: a Mendelian randomization study
Lupus
Alzheimer's disease and rheumatoid arthritis: a mendelian randomization study
Front. Neurosci.
Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators
Am. J. Epidemiol.
Genome-wide association study in 79, 366 European-ancestry individuals informs the genetic architecture of 25-hydroxyvitamin D levels
Nat. Commun.
Association of obesity with inflammation, disease severity and cardiovascular risk factors among patients with ankylosing spondylitis
Int. J. Rheum. Dis.
How does smoking cessation affect disease activity, function loss, and quality of life in smokers with ankylosing spondylitis?
JCR-J. Clin. Rheumatol.
Cited by (11)
Effect of vitamin D on health and disease
2023, Feldman and Pike's Vitamin D: Volume Two: Disease and TherapeuticsVitamin D and human health: evidence from Mendelian randomization studies
2024, European Journal of EpidemiologyCausal relationship between endometriosis with infertility and ankylosing spondylitis
2023, Scientific ReportsSerum vitamin D levels and Sjogren’s syndrome: bi-directional Mendelian randomization analysis
2023, Arthritis Research and TherapyEmerging Concepts in Precision Medicine in Axial Spondyloarthritis
2023, Current Rheumatology Reports
- 1
Contributed equally to this work and should be considered as co-first authors.